🔎 Trials Near Me

Beranda › Glioma › Illinois › Chicago

Uji klinis Glioma di Chicago, IL

13 studi untuk Glioma mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Menerima pesertaFase 1/2
  • University of Chicago Comprehensive Cancer Center, Chicago
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05099003

Targeted Pediatric High-Grade Glioma Therapy

Menerima pesertaStudi observasional
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Menerima pesertaFase 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Usia 12 hingga 39 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Menerima pesertaFase 3
  • University of Chicago, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Menerima pesertaFase 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Usia 3 hingga 39 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05096481

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Menerima pesertaFase 1
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Usia 1 hingga 25 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT04485559

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Menerima pesertaFase 1/2
  • Research Site, Chicago
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT05417594

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

Menerima pesertaFase 1
  • Northwestern Medicine, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07464925

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

Menerima pesertaFase 1/2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Usia 1 hingga 26 · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT06712875

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Menerima pesertaFase awal 1Sukarelawan sehat diterima
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Menerima pesertaFase 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Menerima pesertaFase 1/2
  • Northwestern Memorial Hospital, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06810544

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Menerima pesertaFase 1
  • Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
12 Months – 18 Years · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT04943848

Uji klinis Glioma di kota lain

Studi lain di Chicago

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.